menu search

Cassava sciences stock undervalued with its $124 price target?

Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a...

January 31, 2023, 2:01 am

Royalty pharma: uncorrelated yield from pharmaceutical product in uncertain times

Royalty Pharma plc is an interesting investment fund that buys pharmaceutical royalties and generates a non-correlated yield. With the depressed ...

January 30, 2023, 3:19 pm

Final trades: stryker, davita, biotech and more

The "Halftime Report" traders give their top picks to watch for the second half....

January 30, 2023, 2:27 pm

Beyond cancer® appoints gavin choy, pharmd as chief operating officer

Dr. Choy brings more than 20+ years of pharmaceutical and biotechnology operating experience to Beyond Cancer GARDEN CITY, N.Y. and HAMILTON, Bermuda,...

January 30, 2023, 12:00 pm

Opthea to present at sequire biotechnology conference

MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing no...

January 30, 2023, 6:00 am

Cidara therapeutics: fda approval dead ahead

Today, we are putting the spotlight on small biotech concern Cidara Therapeutics for the first time in ...

January 30, 2023, 5:23 am

What will 2023 bring for alexandria real estate equities?

Alexandria Real Estate Equities is the leading provider of high-demand biotech, agrifood, and life sciences office space. The company saw record leasi...

January 29, 2023, 12:44 pm

What will 2023 bring for alexandria real estate equities?

A slowdown in the biotech and life sciences industry isn't going to stop this top-tier stock from growi...

January 29, 2023, 7:15 am

Aerovate: developing an exciting pah drug, initiating with a buy

Aerovate is a SMID-cap biotech developing an inhaled imatinib for pulmonary arterial hypertension. AV-1...

January 29, 2023, 7:12 am

Jasper therapeutics announces closing of public offering of common stock and full exercise of underwriters’ option to purchase additional shares

REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...

January 27, 2023, 6:10 pm

Anebulo: interesting drug for cannabis intoxication, but the market potential remains unclear

Anebulo pharmaceutical is a US small-cap ($80M market cap) biotech company that is developing a phase 2...

January 27, 2023, 3:49 pm

biotech stocks reward shareholders who handle the bumpy ride

biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulte...

January 27, 2023, 2:56 pm

Biocorrx to present at sequire biotechnology conference on february 2nd

Presentation on Thursday, February 2, 2023 at 2:00 PM ET...

January 27, 2023, 8:30 am

The 3 best biotech stocks under $1 to buy for january

While biotech may be the next big thing, making money through it isn't easy. Indeed, investing in ...

January 26, 2023, 6:06 pm

Why shares of editas medicine jumped this week

It's been a seesaw month for the clinical-stage gene-editing biotech....

January 26, 2023, 6:04 pm

Sartorius stedim biotech s.a. (sdmhf) q4 2022 earnings call transcript

Sartorius Stedim biotech S.A. (OTCPK:SDMHF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM E...

January 26, 2023, 5:38 pm

Akoya bioscience: something special for investing in a spatial bioscience company

I will provide readers the basics of what a spatial biotech offers. A key catalyst should drive the fut...

January 26, 2023, 3:13 pm

Why shares of zencor rose this week

The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago....

January 26, 2023, 2:33 pm

: genelux ipo prices at bottom of range

Genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share range, for its stock market debut Thursday on the ...

January 26, 2023, 11:40 am

How will early 2023 layoffs affect these 5 biotech stocks?

The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new...

January 26, 2023, 4:03 am


Search within

Pages Search Results: